Skip to main content
NeuroWiki
Back to Trials

Clinical Question

Does my basilar artery occlusion patient benefit from EVT?

Synthesises 4 trialsevolution of basilar EVT evidence: BEST/BASICS (neutral) to ATTENTION/BAOCHE (positive)

What does the guideline say?

The trials cited in the guideline's supportive text appear below.

Trials in this question· 4

BEST2020
First RCT of basilar EVT, stopped early; crossover and slow enrollment limit conclusions.
InconclusiveOR 1.74
BASICS2021
EVT ≤6 h for basilar artery occlusion vs medical care did not significantly improve mRS 0–3.
NeutralRR 1.18
ATTENTION2022
EVT within 12 h for basilar artery occlusion (NIHSS ≥10) roughly halves mortality and doubles good outcome.
NNT 4+23% mRS 0–3
BAOCHE2022
EVT 6–24 h for basilar artery occlusion improves mRS 0–3 vs medical therapy.
NNT 5+22% mRS 0–3

Related questions

Does my LVO patient need EVT?

early window, late window, large-core, and MeVO boundary

Perfusion imaging or non-contrast CT for late-window selection?

evolution from CT-perfusion / MRI mismatch (DAWN, DEFUSE-3) to plain-CT and MRI ASPECTS selection (RESCUE-Japan LIMIT, LASTE, SELECT2, ANGEL-ASPECT)

Was this useful?

NeuroWiki is a clinical reference. It does not substitute for your clinical judgment, current guidelines, or your institution's protocol. Verify before acting. Do not enter patient names, MRNs, or dates of birth. Privacy Policy